Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CNMD 
CONMED Corporation (CNMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/10/2025: CNMD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
6 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $61
1 Year Target Price $61
| 0 | Strong Buy |
| 2 | Buy |
| 4 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -48.07% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/10/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.32B USD | Price to earnings Ratio 12.06 | 1Y Target Price 61 |
Price to earnings Ratio 12.06 | 1Y Target Price 61 | ||
Volume (30-day avg) 6 | Beta 1.15 | 52 Weeks Range 42.50 - 76.94 | Updated Date 10/12/2025 |
52 Weeks Range 42.50 - 76.94 | Updated Date 10/12/2025 | ||
Dividends yield (FY) 1.76% | Basic EPS (TTM) 3.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.31% | Operating Margin (TTM) 10.62% |
Management Effectiveness
Return on Assets (TTM) 4.03% | Return on Equity (TTM) 11.69% |
Valuation
Trailing PE 12.06 | Forward PE 27.03 | Enterprise Value 2290391275 | Price to Sales(TTM) 1 |
Enterprise Value 2290391275 | Price to Sales(TTM) 1 | ||
Enterprise Value to Revenue 1.73 | Enterprise Value to EBITDA 9.36 | Shares Outstanding 30954963 | Shares Floating 30678226 |
Shares Outstanding 30954963 | Shares Floating 30678226 | ||
Percent Insiders 0.57 | Percent Institutions 119.76 |
Upturn AI SWOT
CONMED Corporation
Company Overview
History and Background
CONMED Corporation was founded in 1970. Initially focused on electrosurgical products, it has grown through acquisitions and organic development to offer a broad portfolio of surgical devices and equipment.
Core Business Areas
- Orthopedic Surgery: Offers a comprehensive suite of products for sports medicine, arthroscopy, and large bone reconstruction.
- General Surgery: Provides a wide range of surgical devices and equipment, including electrosurgical generators, surgical staplers, and smoke evacuation systems.
Leadership and Structure
Curt R. Hartman is the Chairman of the Board, President, and CEO. The company operates with a functional organizational structure.
Top Products and Market Share
Key Offerings
- Advanced Surgical: Includes LigaSure vessel sealing technology and AirSeal insufflation system. Competitors include Medtronic, Ethicon, and Stryker. Revenue not publicly broken down per product. Market share varies by specific product category within advanced surgical solutions.
- General Competitors: Medtronic,Ethicon,Stryker,Olympus
- General Competitors: Smith & Nephew,Stryker,Zimmer Biomet
- Orthopedics: Includes patient positioning and fluid management products. Competitors include Smith & Nephew, Stryker, and Zimmer Biomet. Revenue not publicly broken down per product. Market share varies by specific product category within orthopedics.
Market Dynamics
Industry Overview
The medical device industry is characterized by innovation, regulation, and consolidation. Demand is driven by an aging population, increasing prevalence of chronic diseases, and technological advancements.
Positioning
CONMED holds a mid-tier position in the medical device market. Its competitive advantages include a diversified product portfolio, established customer relationships, and a focus on innovation.
Total Addressable Market (TAM)
The global medical devices market is estimated to be worth hundreds of billions of dollars. CONMED addresses a substantial portion of this TAM, particularly in its focused segments. Its TAM is continually affected by innovative products.
Upturn SWOT Analysis
Strengths
- Diversified product portfolio
- Established customer relationships
- Focus on innovation
- Strong brand recognition in key segments
Weaknesses
- Smaller scale compared to major competitors
- Dependence on key product lines
- Operational efficiency improvements needed
- Vulnerability to economic fluctuations
Opportunities
- Expanding into emerging markets
- Developing new products and technologies
- Acquiring complementary businesses
- Leveraging digital health solutions
Threats
- Intense competition
- Stringent regulatory requirements
- Pricing pressures
- Product liability claims
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Stryker (SYK)
- Johnson & Johnson (JNJ)
Competitive Landscape
CONMED's competition includes some of the largest medical device companies globally. It has a stronger position in certain niche areas but is generally smaller in scale.
Major Acquisitions
Biorez, Inc.
- Year: 2022
- Acquisition Price (USD millions): 85
- Strategic Rationale: Biorez's BioBrace implant reinforces soft tissue repairs and represents an expansion of CONMED's sports medicine portfolio.
Growth Trajectory and Initiatives
Historical Growth: Growth is dependent on product lifecycle management and innovation.
Future Projections: Analyst estimates are needed for future revenue and growth
Recent Initiatives: Recent acquisitions and product launches are designed to improve market position.
Summary
CONMED is a mid-sized medical device company with a diversified portfolio and established customer relationships. Innovation and strategic acquisitions will be key to future growth. Intense competition from larger players and evolving regulations pose challenges. The company needs to continue to drive operational efficiency and expand its market presence to sustain growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- CONMED Corporation Investor Relations
- SEC Filings
- Market Research Reports
- Analyst Reports
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Market share data is approximate and may vary depending on the source and methodology.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CONMED Corporation
Exchange NYSE | Headquaters Largo, FL, United States | ||
IPO Launch date 1987-07-23 | President, CEO & Director Mr. Patrick J. Beyer | ||
Sector Healthcare | Industry Medical Devices | Full time employees 3900 | Website https://www.conmed.com |
Full time employees 3900 | Website https://www.conmed.com | ||
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.